Live Breaking News & Updates on United States India Chamber

Stay updated with breaking news from United states india chamber. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

India premier destination for conducting global clinical trials, says Harvard scholar

India premier destination for conducting global clinical trials, says Harvard scholar
dailyexcelsior.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailyexcelsior.com Daily Mail and Mail on Sunday newspapers.

United States , Harvard University , Narendra Modi , Mrinalini Darswal , United States India Chamber , Prime Minister Narendra Modi ,

Indian pharmaceutical industry set for major transformation: Dilip Shanghvi

At an annual meeting of the USA-India Chamber of Commerce in Boston, Shanghvi told a gathering of leading multinational drug makers about the "clear positive improvements" that are taking place in India. Sun Pharma itself has built a pipeline of over 10 specialty and innovative drugs in the US. It s done this through acquisitions of late-stage drugs in clinical trials and building commercial teams around them. For Indian companies that have grown by making copies of innovative drugs, gaining presence in innovative drugs is considered tough as this segment is dominated by giant corporations such as Pfizer, Novartis, Roche, Eli Lilly and Bristol Myers Squibb. ....

United States , Christopher Viehbacher , Eli Lilly , Shanghvi Sun Pharma , Zydus Lifesciences , Hari Bhartia , Sun Pharma , Dilip Shanghvi , Bristol Myers Squibb , India Chamber , United States India Chamber , Bristol Myers , Jubilant Bhartia ,

India becoming attractive for clinical trials, says pharma industry leaders

India becoming attractive for clinical trials, says pharma industry leaders
dailyexcelsior.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailyexcelsior.com Daily Mail and Mail on Sunday newspapers.

United States , Badhri Srinivasan , Sarah Sheikh , Uli Broedl , Christopher Corsico , Lalitk Jha , Global Clinical Development , United States India Chamber , Boehringer Ingelheim , Global Development , Global Head Of Development , Cosmetics Act , Global Clinical Operations , Annual Biopharma , Healthcare Summit , Global Head ,

Novartis: India becoming attractive for clinical trials, says pharma industry leaders

Over the past decade, India has seen significant improvements in its clinical trial landscape, with a 15-18% growth in phase two and three trials. This growth is attributed to 10 modifications to the Drugs and Cosmetics Act since 2013, aimed at simplifying the process. Despite these advancements, conducting trials in India can still be challenging. Experts note that India s modernizing private hospital networks and improved infrastructure make it an attractive location for trials, with potential for further growth and collaboration in the future. ....

United States , Sarah Sheikh , Christopher Corsico , Uli Broedl , Badhri Srinivasan , Global Head Of Development , Global Clinical Development , Boehringer Ingelheim , Global Development , United States India Chamber , Cosmetics Act , Global Clinical Operations , Annual Biopharma , Healthcare Summit , Global Head , Clinical Trials , Pharma Industry ,

India Emerges as a Prime Destination for Clinical Trials: Pharma Industry Leaders

India Emerges as a Prime Destination for Clinical Trials: Pharma Industry Leaders
devdiscourse.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from devdiscourse.com Daily Mail and Mail on Sunday newspapers.

United States , Christopher Corsico , Uli Broedl , Badhri Srinivasan , Sarah Sheikh , United States India Chamber , Global Development , Global Clinical Development , Boehringer Ingelheim , Global Head Of Development , Cosmetics Act , Global Clinical Operations , Annual Biopharma , Healthcare Summit , Global Head ,